Home / News

News

Invectys Inc. to Participate in the 9TH International C...

  9th International Conference on HLA-G July 4th – 5th 2022 Fondation Singer-Polignac, 43 Avenue Georges Mandel, 75116 Paris     Invectys will be…

Read more

Invectys, MD Anderson and CTMC Announce Strategic Colla...

Invectys, MD Anderson and CTMC Announce Strategic Collaboration for CAR T Cell Therapy Development Houston, Texas, USA – June 16, 2022 – Invectys, Inc. (Invectys),…

Read more

Invectys, Inc. Appoints François Lescure as General Ma...

Invectys, Inc. Appoints François Lescure as General Manager of its R&D Subsidiary, Invectys, SAS Houston, Texas, USA – April 11, 2022 (GLOBE NEWSWIRE) –…

Read more

Wayne A. Marasco, M.D., Ph.D. joins Invectys’ Scienti...

Wayne A. Marasco, M.D., Ph.D. joins Invectys’ Scientific Advisory Board Houston, TX, USA, March 8, 2022 (GLOBE NEWSWIRE) — Invectys, Inc. of Houston, Texas,…

Read more

Invectys appoints Jian Cao, Ph.D., as Vice President, P...

Invectys appoints Jian Cao, Ph.D., as Vice President, Pharmaceutical Development Houston, TX, USA, March 1st, 2022 (GLOBE NEWSWIRE) — Invectys, Inc. of Houston,…

Read more

Invectys to Provide 2022 Business Outlook at the H.C. W...

Invectys to Provide 2022 Business Outlook at the H.C. Wainwright Bioconnect Virtual Conference Houston, Texas, USA – January 6th, 2022 (GLOBE NEWSWIRE) –…

Read more

INVECTYS INC. TO PARTICIPATE IN THE 2022 JP MORGAN HEAL...

Houston, Texas, USA, Dec. 16, 2021 (GLOBE NEWSWIRE) — Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development…

Read more

INVECTYS INC. TO PARTICIPATE IN THE 2021 H.C. WAINWRIGH...

Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) — Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the…

Read more